Dosage form having a saccharide matrix

Details for Australian Patent Application No. 2004216559 (hide)

Owner ALK-Abello A/S

Inventors Lundegaard, Annette Rommelmayer; Houghton, Christian Gauguin

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004216559

PCT Pub. Number WO2004/075875

Priority PA 2003 00318 28.02.03 DK; 60/465,383 25.04.03 US

Filing date 24 February 2004

Wipo publication date 10 September 2004

Acceptance publication date 27 May 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 39/35 (2006.01) Medicinal preparations containing antigens or antibodies - Allergens

A61K 39/36 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

15 September 2005 PCT application entered the National Phase

  PCT publication WO2004/075875 Priority application(s): WO2004/075875

27 May 2010 Application Accepted

  Published as AU-B-2004216559

23 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004216563-A medical device having a coating comprising hydrogen peroxide and package therefore

2004216554-Subcutaneously-administered ganglioside-based vaccine compositions